$NXE

Top Nuclear Stocks to Watch, According to Jefferies

Jefferies ranked nuclear sector stocks, preferring NexGen Energy (NXE) for near-term uranium mining, Cameco (CCJ) for integrated fuel-cycle exposure, and Kazatomprom (KAP LI) for low-cost production. BWX Technologies (BWXT) and Mirion Technologies (MIR) offer alternative nuclear exposure. Recent earnings reports varied, with some meeting or exceeding expectations.

Original reporting
Published Sep 3, 2026, 8:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 3, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefSector analysis
Primary signal
$NXE
Bullish
medium confidence
Mentioned
$NXE · $CCO · $BWXT · $MIR
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NXEBullishMed
01

Why it matters

The list provides fresh data points for investors seeking exposure to nuclear energy, with several companies reporting new earnings or contracts.

02

Market read

The article introduces new corporate data that could shift short‑term positioning in the nuclear sector.

03

What to watch

Regulatory and permitting risks could delay project timelines.

Relevance 6/10Novelty 5/10Timing: recent Q2 2026 results

Background

Jefferies released a ranking of preferred nuclear sector stocks, combining recent earnings and project updates.

Company-level read

Ticker impact

$NXEBullishMedium confidence
Context

NexGen Energy reported a smaller-than-expected Q2 2026 loss and disclosed ongoing discussions with BHP about the Rook I project.

Expected impact

possible price rally if partnership materializes

Evidence & confidence

New loss figure and BHP talks could improve investor sentiment.

$CCOBearishMedium confidence
Context

Cameco posted Q2 2026 earnings that missed analyst expectations while maintaining its full‑year production outlook.

Expected impact

downside pressure pending guidance clarity

Evidence & confidence

First report of earnings miss; investors may react negatively.

$BWXTBullishHigh confidence
Context

BWX Technologies beat Q2 2026 earnings expectations and secured a U.S. Army contract for its advanced nuclear reactor technology under the Janus program.

Expected impact

short‑term rally likely

Evidence & confidence

New contract and earnings beat are fresh catalysts.

$MIRNeutralLow confidence
Context

Mirion Technologies reported mixed Q2 2026 results, with adjusted EPS beating estimates but revenue slightly below forecasts.

Expected impact

limited price movement

Evidence & confidence

Partial beat does not provide a clear directional bias.

Market effects

Highlights renewed investor interest in nuclear energy and uranium exposure.

Positive for North American and Canadian mining equities.

May influence global commodity sentiment on uranium.

Counterpoint

Valuation concerns remain high for non‑producing miners like NexGen.

Key entities

  • Jefferies

    Brokerage that compiled the nuclear stock ranking.

Related articles

$BWXTMed

Jim Cramer Favors BWX Technologies (BWXT) Over Cameco (CCJ)

Jim Cramer prefers BWX Technologies (BWXT) over Cameco (CCJ) for nuclear power investment, citing BWXT's stronger recent performance and Cameco's longer-term potential. BWXT reported Q2 revenue of $901.6M, up 18% YoY, and raised 2026 guidance. Cameco's Q2 uranium segment revenue fell to C$252M from C$352M YoY, but maintained production outlook. Both companies saw increased hedge fund interest.

$BWXTHigh

BWXT Looks 4.3% Undervalued on GF Value™

Guggenheim initiated coverage on BWX Technologies (BWXT) with a Buy rating and $192 price target, citing its strategic nuclear sector position. GF Value™ indicates BWXT is 4.3% undervalued at $148.53 vs. $155.28 intrinsic value. The company has a GF Score™ of 93/100, strong growth, and profitability but faces insider selling and premium valuation concerns.

$BWXTMed

Bwxt stock hits 52-week low at 146.1 USD

BWX Technologies Inc. (BWXT) stock hit a 52-week low of $145.91, down 40% from its high. Q2 2026 earnings beat estimates at $1.07 EPS, but revenue missed at $901.6M. Sales rose 18% YoY, and the company raised full-year free cash flow guidance to $345M-$360M. BWXT's backlog grew to $8.4B, up 40% YoY. Jefferies initiated coverage with a Buy rating, and Wells Fargo upgraded to Equal Weight.

$CCOMed

Clear Channel Outdoor (CCO) Grows Fastest Right Before Going Private

Clear Channel Outdoor (CCO) reported Q2 revenue growth of 8.7% to $438M, driven by advertising demand ahead of the 2026 FIFA World Cup. The company is set to be acquired for $2.43 per share, with the deal expected to close by Q3 2026. Adjusted EBITDA rose 11.6% to $143.4M, while net loss widened to $10M due to rising costs. The company sold its Spain business for $132.3M to reduce debt.

$BWXTMed

Can BWXT's Canadian Lab Role Strengthen Nuclear Services Growth?

BWX Technologies (BWXT) is expanding its nuclear services through a new Canadian lab management role via a joint venture. The contract began in December 2025, complementing BWXT's broader strategy. The Kinectrics acquisition, completed in May 2025, is key to this expansion. BWXT's commercial revenues grew 62.8% YoY to $853.1M in 2025, with Kinectrics contributing $231M. Analysts expect EPS growth of 18.45% and 10.73% for 2026 and 2027, respectively.

$CCJMed

Jefferies Sees Cameco (CCJ) and BWXT as Winners in the Nuclear Boom

Jefferies initiated coverage of Cameco (CCJ) and BWXT (BWXT) with 'Buy' ratings, setting price targets of $138 and $181 respectively, citing strong long-term prospects in nuclear energy. CCJ, a major uranium producer, and BWXT, a nuclear reactor provider, are positioned to benefit from global and U.S. initiatives to expand nuclear capacity. Both companies face risks, including uranium price volatility for CCJ and execution challenges for BWXT.